Man and girl with Dexcom device on her arm playing with balls at the beach

Introducing the Dexcom G7 CGM System

  • Learn more
The Dexcom Difference
As a pioneer and a leader in rtCGM, Dexcom’s goal is to simplify and improve diabetes management for every possible person with diabetes.
No finger pricks icon

Real-time Continuous Glucose Readings.

No finger pricks*, no scanning ever!
Arrow and target icon

Exceptional Accuracy4

Better informed treatment desicions.
Speaker icon

Intuitive Features.

Customisable alerts to notify you of highs and lows.
HbA1C icon

Proven Results.

Lowered HbA1C and improved time-in-range.1-3,5,6
*Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Introducing the Dexcom G7 CGM System
Powerfully simple glucose monitoring
Dexcom G7 for T1 diabetes
Gabriela sitting on sofa with dog
"This little sensor allows me to set boundaries. It alerts me so I can adjust my insulin in advance. It shows how each food affects me, helps me to choose what to eat and when. I know how sports and stress affect me, I track my low glucose trends constantly!”
Gabriela, Dexcom Warrior

Gabriela is a sponsored spokesperson of Dexcom.
Elena in a field of sunflowers
"Thanks to my Dexcom CGM, I worry less about my glucose levels and spend more time doing the things I love."
Elena, Dexcom Warrior
Elena is a sponsored spokesperson of Dexcom.
Dexcom Support
Dexcom is committed to helping you have a positive experience with our CGM systems. From getting started, to tutorials, and FAQs - Dexcom is with you every step of the way.
FAQ Icon

Frequently Asked Questions

Do you have questions about your Dexcom CGM system? Read the most commonly asked questions on our FAQ pages.
References:
*Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Smart device sold separately. For a list of compatible smart devices, visit
dexcom.com/compatibility.
‡ Optional receiver sold separately.
§ Based on a reduced risk for complications with better glycaemic control. DCCT Research Group. N Engl J Med. 1993;329(14):977-86
‖ Time in range was defined as 3.9-10 mmol/L - 70-180 mg/dL.
1 Šoupal J, et al. 2020;43:37- 43. Study included non-Dexcom rtCGM systems.
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Lind M, et al. Diabetes Care. 2021;44(1):141-149.
4 Dexcom G6 and Dexcom G7
User Guides.
5 Beck RW et al. Ann Intern Med. 2017;167(6):365-374.
6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147.

© 2026 Dexcom, Inc. All rights reserved.

LB flag

LB